Trial intelligence / Profile preview

Study of Nimodipine and Acetaminophen on Postictal Symptoms after ECT

2019-000617-37Phase 4Active

Sponsor
Rijnstate
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of nimodipine and acetaminophen in Postictal state and confusion, sponsored by Rijnstate. Primary endpoint: Time to EEG normalization. Started Jul 2019; status: active.

02

Drugs

nimodipineacetaminophen
03

Conditions

Postictal stateconfusion

Beyond the preview

Go deeper on 2019-000617-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-000617-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call